MEYHOFF, T.S., P.B. HJORTRUP, M.H. MOLLER, J. WETTERSLEV, T. LANGE, M.B.N KJR, A.B. JONSSON, C.J.S HJORTSO, M. CRONHJORT, J.H. LAAKE, S.M. JAKOB, M. NALOS, V. PETTIL, I. VAN DER HORST, M. OSTERMANN, P.. MOUNCEY, K. ROWAN, M. CECCONI, R. FERRER, M.L.N.G. MALBRAIN, C. AHLSTEDT, S. HOFFMANN, M.H. BESTLE, L. NEBRICH, L. RUSSELL, M. VANG, M.L. RASMUSSEN, C. SOLLING, B.S. RASMUSSEN, A.C. BROCHNER a A. PERNER. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan. Acta Anaesthesiologica Scandinavica. HOBOKEN: WILEY, 2019, roč. 63, č. 9, s. 1262-1271. ISSN 0001-5172. Dostupné z: https://dx.doi.org/10.1111/aas.13434.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan
Autoři MEYHOFF, T.S. (garant), P.B. HJORTRUP, M.H. MOLLER, J. WETTERSLEV, T. LANGE, M.B.N KJR, A.B. JONSSON, C.J.S HJORTSO, M. CRONHJORT, J.H. LAAKE, S.M. JAKOB, M. NALOS, V. PETTIL, I. VAN DER HORST, M. OSTERMANN, P.. MOUNCEY, K. ROWAN, M. CECCONI, R. FERRER, M.L.N.G. MALBRAIN, C. AHLSTEDT, S. HOFFMANN, M.H. BESTLE, L. NEBRICH, L. RUSSELL, M. VANG, M.L. RASMUSSEN, C. SOLLING, B.S. RASMUSSEN, A.C. BROCHNER a A. PERNER.
Vydání Acta Anaesthesiologica Scandinavica, HOBOKEN, WILEY, 2019, 0001-5172.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30230 Other clinical medicine subjects
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW CLASSIC
Impakt faktor Impact factor: 2.050
Kód RIV RIV/00216224:14110/19:00124330
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1111/aas.13434
UT WoS 000477274600001
Klíčová slova česky INTENSIVE;CARESEPSIS;PROTOCOL; MISSING DATA; RESUSCITATION; MANAGEMENT; MORTALITY; VOLUMES; ADULTS
Klíčová slova anglicky INTENSIVE;CARESEPSIS;PROTOCOL; MISSING DATA; RESUSCITATION; MANAGEMENT; MORTALITY; VOLUMES; ADULTS
Štítky Excelence Science, INT, MU, user
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 17. 5. 2022 13:17.
Anotace
Introduction Intravenous (IV) fluid is a key intervention in the management of septic shock. The benefits and harms of lower versus higher fluid volumes are unknown and thus clinical equipoise exists. We describe the protocol and detailed statistical analysis plan for the conservative versus liberal approach to fluid therapy of septic shock in the Intensive Care (CLASSIC) trial. The aim of the CLASSIC trial is to assess benefits and harms of IV fluid restriction versus standard care in adult intensive care unit (ICU) patients with septic shock. Methods CLASSIC trial is an investigator-initiated, international, randomised, stratified, and analyst-blinded trial. We will allocate 1554 adult patients with septic shock, who are planned to be or are admitted to an ICU, to IV fluid restriction versus standard care. The primary outcome is mortality at day 90. Secondary outcomes are serious adverse events (SAEs), serious adverse reactions (SARs), days alive at day 90 without life support, days alive and out of the hospital at day 90 and mortality, health-related quality of life (HRQoL), and cognitive function at 1 year. We will conduct the statistical analyses according to a pre-defined statistical analysis plan, including three interim analyses. For the primary analysis, we will use logistic regression adjusted for the stratification variables comparing the two interventions in the intention-to-treat (ITT) population. Discussion The CLASSIC trial results will provide important evidence to guide clinicians' choice regarding the IV fluid therapy in adults with septic shock.
Návaznosti
90090, velká výzkumná infrastrukturaNázev: CZECRIN II
VytisknoutZobrazeno: 11. 5. 2024 15:17